Taysha Gene Therapies (TSHA) Earnings Date & Reports
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TSHA is expected to report earnings to rise 8.44% to -9 cents per share on March 04
Q4'25
Est.
$-0.10
Q3'25
Est.
$-0.09
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.01
The last earnings report on November 04 showed earnings per share of -9 cents, meeting the estimate of -9 cents. With 589.90K shares outstanding, the current market capitalization sits at 1.13B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TSHA showed earnings on November 04, 2025. You can read more about the earnings report here.